For example, expression of high PD‐1/PD‐L1 in patients with metastatic melanoma was associated with significantly improved progression‐free survival and overall survival, and these were also more likely to respond to anti‐PD‐1 monotherapy. This evidence concerns the gene CD274 and metastatic melanoma.